Accurate prediction of drug metabolites and enzyme selectivity is essential for rational drug design and safety assessment. However, existing computational approaches are often limited to specific enzyme families or reaction types, lacking the capaci...
Programmable design of RNA sequences with defined functions remains a central challenge in biology. Despite recent advances, existing RNA generative models lack robust controllable design capabilities and are constrained by short context windows, lim...
Off-target binding remains a leading cause of drug attrition, yet no method exists for rapidly quantifying small-molecule promiscuity across the human proteome. Here, we define promiscuity as the mean predicted binding affinity over 15,405 human prot...
Background: Plants produce diverse metabolites with potential benefits for human health. However, the metabolomes of plant callus cultures-cell cultures analogous to stem cells-remain poorly characterized in terms of their functional relevance. Metho...
The construction of accurate enzyme-constrained genome-scale models (ecGEMs) remains a critical challenge in systems biology, limited by sparse kinetic data and the need for biologically meaningful representations. This work presents an integrated fr...
Single-cell foundation models are reshaping biology by learning transferable representations of cellular state from millions of profiles. These models support annotation, denoising, cross-modal mapping and, increasingly, prediction of responses to ge...
Pharmaceutical patents contain vast Structure-Activity Relationship tables documenting protein-ligand binding data that are technically public yet computationally inaccessible, rendering this wealth of data effectively dark - trapped in unstructured ...
Spatial transcriptomic (ST) technologies enable the measurement of gene expression directly within tissue sections while preserving spatial context. Many ST platforms additionally generate paired histological images alongside spatially resolved trans...
Motivation: Encoding antibodies (Abs) and nanobodies (Nbs) as mRNA enables in vivo production of therapeutic proteins. However, this approach requires meeting two species-dependent requirements: the mRNA encoding must support efficient expression in ...
T-cell recognition of infected and malignant cells is elicited by the binding of heterodimeric T-Cell Receptors (TCRs) to epitopes and both the TCR and the TCR{beta} chains play a key role in these interactions. Machine learning tools trained on data...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.